Skip to main content
. 2021 Dec 6;8:732042. doi: 10.3389/fmed.2021.732042

Figure 6.

Figure 6

Schema of the possible mechanism of antifibrosis action of TSF. In the TGF-β/smad pathway, TSF decreased the expression of TGF-β1, inhibited the phosphorylation of Smad2/3, and increased the expression of Smad7, which promoted the degradation of catenin. Meanwhile, TSF also inhibited the Wnt pathway and further promoted β-catenin phosphorylation and degradation. The green arrow represents the effect of TSF.